Assembly Line

Spore.Bio raises €8M for real-time pathogen detection in FMCG factories

📅 Date:

🔖 Topics: Funding Event

🏢 Organizations: Spore.Bio, LocalGlobe

Spore.Bio announced that it has raised €8 million in Pre-Seed funding led by LocalGlobe to solve the critical health and safety challenges threatening the global fast-moving consumer goods (FMCG) market. Besides LocalGlobe, the round also included participation from EmergingTech Ventures, No Label Ventures, Famille C (Clarins Family Office), Better Angle, Mehdi Ghissassi (Google DeepMind), Roxane Varza (Station F) and more. The funding will be used to accelerate the development and deployment of Spore.Bio’s AI-powered technology and grow its team.

Spore.Bio has built the world’s first device for detecting pathogens immediately, directly on the factory floor. It uses advanced machine learning models to train its system to identify the concentration of bacteria in food, drink, pharmaceuticals and cosmetic products before alerting quality managers to the potential risks. Previously, quality sampling would typically take between five and 20 days, with products having to be sent off-site to external labs, at great time and financial expense.

Read more at Tech EU